Expansion of the Overseas Medical Institution Business
First written in FY2024. 4 of 7 entries say "Advanced", first in 2026-04-30. Latest entry: 2026-07-30.
No other company in this theme has enough history to compare yet.
- FY2026AdvancedAnnual report
「Overseas, in addition to expanding the business base and improving competitiveness through roll-up M&A of existing podiatry and lower-extremity venous disease clinics, we will focus on opening new U.S. OBLs (Office-Based Laboratories).」
Opening new U.S. OBLs has been added explicitly to clinic M&A as a means of overseas expansion. - FY2026-H1RestatedAnnual report
「Overseas, we operate podiatry and lower-extremity venous disease clinics and conduct other activities in the United States, while providing management support to healthcare institutions in Southeast Asia.」
The overseas business continues to comprise U.S. clinic operations and healthcare institution support in Southeast Asia. - FY2024First statedAnnual report
「To expand overseas the management support expertise developed through healthcare institutions in Japan, an advanced aging society, we aim to further expand our businesses in the United States, Vietnam and Indonesia. Overseas, we will further expand existing podiatry and lower-extremity venous disease clinics and develop new clinics.」
The goal of expanding the healthcare institution business across the United States, Vietnam and Indonesia is stated explicitly for the first time.